title: Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2).
authors.affiliation: Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
authors.forename: J W
authors.initials: JW
authors.lastname: Baars
authors.forename: J
authors.initials: J
authors.lastname: Wagstaff
authors.forename: C E
authors.initials: CE
authors.lastname: Hack
authors.forename: G J
authors.initials: GJ
authors.lastname: Wolbink
authors.forename: A J
authors.initials: AJ
authors.lastname: Eerenberg-Belmer
authors.forename: H M
authors.initials: HM
authors.lastname: Pinedo
mesh_terms: D000799:Angioedema / Q000139:chemically induced*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D014581:Urticaria / Q000139:chemically induced*
chemical_list: D007376:Interleukin-2